capecitabine has been researched along with Ascites in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Abe, S; Ami, K; Hamasaki, S; Harada, T; Katsuno, A; Kitagawa, Y; Machida, T; Nakanishi, A; Tamura, N; Umetani, N | 1 |
Higashide, S; Nio, M; Yata, Y; Yonenaga, Y | 1 |
Kondo, C; Matsuo, K; Mizota, A; Muro, K; Sato, Y; Shitara, K; Tajika, M; Takahari, D; Ura, T | 1 |
Chen, Y; Feng, Y; Li, Q; Liu, TS; Wang, ZM; Zhuang, RY | 1 |
4 other study(ies) available for capecitabine and Ascites
Article | Year |
---|---|
[Two Cases of Peritoneal Dissemination of Gastric Cancer Treated with CART Followed by Chemotherapy].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Ascites; Capecitabine; Female; Humans; Male; Middle Aged; Oxaliplatin; Peritoneal Neoplasms; Stomach Neoplasms | 2020 |
[A Case of Alcoholic Liver Disease Presenting as Prominent Accumulation of Ascites Associated with Liver Damage Due to CapeOX].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Capecitabine; Chemoradiotherapy; Humans; Liver Diseases, Alcoholic; Male; Organoplatinum Compounds; Oxaliplatin; Rectal Neoplasms | 2017 |
Fluoropyrimidine plus cisplatin for patients with advanced or recurrent gastric cancer with peritoneal metastasis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Capecitabine; Cisplatin; Deoxycytidine; Disease-Free Survival; Drug Combinations; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oxonic Acid; Peritoneal Neoplasms; Retrospective Studies; Stomach Neoplasms; Survival Rate; Tegafur; Time Factors; Treatment Outcome | 2013 |
[A pilot study of chemotherapy combined with intraperitoneal perfusion of cytokine-induced killer cells for advanced gastric cancer patients with ascites].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Ascites; Capecitabine; Combined Modality Therapy; Cytokine-Induced Killer Cells; Deoxycytidine; Female; Fluorouracil; Humans; Immunotherapy, Adoptive; Male; Middle Aged; Oxaloacetates; Pilot Projects; Stomach Neoplasms; Treatment Outcome | 2013 |